Marine Guignant, Billal Tedbirt, Dedee F Murrell, Masayuki Amagai, Valeria Aoki, Johannes Bauer, Giuseppe Ciancinni, Donna Culton, Maryam Daneshpazhooh, Dipankar De, Janet Fairley, Russell Hall, Soo-Chan Kim, Neil J Korman, Cezary Kowalewski, Daniel Mimouni, Aikaterini Patsatsi, Vivien Hebert, Marwah Adly Mohamed Saleh, Enno Schmidt, Eli Sprecher, Soner Uzun, Vanessa Venning, Victoria P Werth, Detlef Zillikens, Pascal Joly
Many treatments are currently proposed for treating patients with bullous pemphigoid (BP). We assessed treatment modalities of BP depending on the different countries, BP extent, and patients' comorbidities. We surveyed worldwide experts about how they treat patients with BP. A total of 61 experts from 27 countries completed the survey. Severe and moderate BP were treated with oral prednisone (61.4 and 53.7%, respectively) or superpotent topical corticosteroids (CSs) (38.6 and 46.3%, respectively). Conventional immunosuppressants were more frequently combined with oral prednisone (74...
July 2022: JID innovations